Skip to content
MedsAcross

Brand family

Bysanti

Milsaperidone · Vanda Pharmaceuticals
United States
Presentations
8
Markets
1

Bysanti is a brand of Milsaperidone marketed by Vanda Pharmaceuticals, with 8 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Milsaperidone
Brand owner
Vanda Pharmaceuticals
Registered in
United States
Strengths and forms
kit, 1 mg tablet, 10 mg tablet, 12 mg tablet, 2 mg tablet, 4 mg tablet, 6 mg tablet, 8 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Bysanti kitOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 1 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 10 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 12 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 2 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 4 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 6 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request
Bysanti 8 mg tabletOralVanda PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Bysanti

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.